NDAA yields 2.71% · PFE yields 6.13%● Live data
📍 PFE pulled ahead of the other in Year 9
Combined, NDAA + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of NDAA + PFE for your $10,000?
NDAA aims to maximize return opportunities by adapting investments to market shifts through a proprietary, data-driven, 360-degree approach. This serves as a broad asset allocation guide for a selection of passively managed ETFs, integrating data from four key pillars: macroeconomic, fundamental, technical, and sentiment analyses. The strategy allows for a holistic view of market conditions and dynamically shifts assets across equities, fixed income, commodities, and money markets. The raw data inputs utilized are sourced from market data providers such as Bloomberg, S&P, MSCI, and others. Typically, the fund targets a 60/40 allocation to equities and bonds, with adjustments made based on prevailing market conditions. Note that the portfolio may fully switch to either equities or bonds. Holdings will generally consist of 5 to 20 underlying ETFs and may also include cash or cash equivalents. On a monthly basis, the fund reviews its holdings and may experience a high portfolio turnover rate.
Full NDAA Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.